Searchable abstracts of presentations at key conferences in endocrinology

ea0092ps1-01-07 | Cancer | ETA2023

Type 2 diabetes and obesity are not likely to be risk factors for thyroid cancer

Grimmichova Tereza , Kuklikova Vlasta , Bulanova Barbora , Pacesova Petra , Vaclavikova Eliska , Moravcova Jitka , Novak Zdenek , Mastnikova Karolina , Vankova Marketa

Background: Patients with type 2 diabetes (T2DM) are generally known to have increased risk of various types of cancer. However, the studies addressing the association between T2DM and thyroid cancer are heterogeneous and inconclusive. The aim of our study was to evaluate the patients who have already undergone thyroid surgery with histologically confirmed results as the ‘gold standard’.Methods: A retrospective study in 102 patients (74 women a...

ea0092ps3-28-05 | Translational 2 | ETA2023

Pediatric thyroid nodules with germline and somatic DICER1 variants

Mastnikova Karolina , Bulanova Barbora , Sykorova Vlasta , Vaclavikova Eliska , Moravcova Jitka , Katra Rami , Vlcek Petr , Kodetova Daniela , Procykova Kristyna , Vcelak Josef , Bendlova Bela

Objectives: Pathogenic variants in the DICER1 gene can be found in both benign and malignant thyroid nodules, more often in pediatric patients. Somatic pathogenic variants in "hotspot" regions can coexist with germline variants in other regions of the DICER1 gene, which are associated with DICER1 syndrome, an autosomal dominantly inherited disease that predisposes to the development of various tumors from childhood. In addition to thyroid tumors, pleu...

ea0092op-12-05 | Oral Session 12: Emerging Insights into Thyroid Cancer Genetics | ETA2023

Braf fusion genes in a large cohort of thyroid carcinomas

Bulanova Barbora , Sykorova Vlasta , Mastnikova Karolina , Vaclavikova Eliska , Moravcova Jitka , Vlcek Petr , Lastuvka Petr , Katra Rami , Bavor Petr , Novakova Kodetova Daniela , Chovanec Martin , Drozenova Jana , Astl Jaromir , Hrabal Petr , Vcelak Josef , Bendlova Bela

Objectives: Effective patient management is about finding a balance between overtreatment and undertreatment. Finding the border is very difficult due to the hardly predictable development of carcinoma. Molecular markers and their testing could help distinguish between low-grade and high- grade carcinomas. One of these molecular markers is a BRAF fusion gene. The aim of this study was to identify BRAF fusion genes in thyroid carcinomas, to correlate them with...

ea0092ps1-08-09 | Translational 1 | ETA2023

Identification of rare braf variants in thyroid nodules

Kuklikova Vlasta , Bulanova Barbora , Vaclavikova Eliska , Moravcova Jitka , Mastnikova Karolina , Vlcek Petr , Katra Rami , Novakova Kodetova Daniela , Lastuvka Petr , Bavor Petr , Drozenova Jana , Chovanec Martin , Vcelak Josef , Bendlova Bela

Objectives: The substitution BRAF p.V600E is the most common genetic cause of the papillary thyroid carcinoma (PTC) and represents more than 95% genetic variants in BRAF gene. Other rare variants in the BRAF gene include other substitutions (e.g. p.K601E), small deletions or insertions close to codon 600. The aim of this study was to analyze a large cohort of thyroid nodules for rare genetic variants in the BRAF gene.M...

ea0099p367 | Thyroid | ECE2024

ALK fusion genes in a large cohort of thyroid carcinomas

Bulanova Barbora , Kuklikova Vlasta , Mastnikova Karolina , Vaclavikova Eliska , Carkova Jitka , Vlcek Petr , Lastuvka Petr , Katra Rami , Bavor Petr , Kodetova Daniela , Chovanec Martin , Drozenova Jana , Astl Jaromir , Soukup Jiri , Vcelak Josef , Bendlova Bela

Objectives: ALK fusion genes are a rare genetic alteration and have been described in various t types of thyroid carcinomas, particularly in papillary thyroid carcinomas (PTCs), poorly differentiated thyroid carcinomas (PDTCs) and anaplastic thyroid carcinomas (ATCs). The aim of this study was to identify ALK fusion genes in thyroid carcinoma samples, correlate them with clinical and histopathological features, and determine the prognostic significance of <em...

ea0099p376 | Thyroid | ECE2024

PTEN variants in thyroid tumors of czech patients

Mastnikova Karolina , Bulanova Barbora , Kuklikova Vlasta , Vaclavikova Eliska , Carkova Jitka , Hrckulakova Karolina , Katra Rami , Vlcek Petr , Kodetova Daniela , Chovanec Martin , Drozenova Jana , Matej Radoslav , Astl Jaromir , Hlozek Jiri , Soukup Jiri , Vcelak Josef , Bendlova Bela

Objectives: Phosphatase and tension homolog (PTEN) is a part of signal pathways which are essential for cell proliferation, cell cycle progression, and apoptosis. Variants in the PTEN gene occur in different types of thyroid tumors with unclear diagnostic and prognostic impact. Most variants are somatic, but they can also be germline, which are associated with PTEN hamartoma tumor syndrome (PHTS). PHTS includes Cowden syndrome, which is characterized by hamartomas, an...

ea0101ps2-11-08 | Basic thyroid cancer research-1 | ETA2024

TSHR variants in benign and malignant thyroid tumors

Bendlova Bela , Bulanova Barbora , Mastnikova Karolina , Kuklikova Vlasta , Vaclavikova Eliska , Carkova Jitka , Vlcek Petr , Lastuvka Petr , Katra Rami , Bavor Petr , Kodetova Daniela , Chovanec Martin , Drozenova Jana , Astl Jaromir , Soukup Jiri , Vcelak Josef

Background: Variants of the TSHR gene occur in different types of thyroid tumors. The importance of their molecular testing and the clinical impact is unclear. The aim of this study was to detect TSHR variants in a large cohort of malignant, low-risk and benign thyroid tumors and correlate them with clinical and histopathological data.Methods: The cohort consisted of 885 fresh frozen thyroid tumor samples (455 malignant tumors, 52 low-r...

ea0101ps3-24-07 | Translational thyroid cancer research-2 | ETA2024

DNA methylation in the thyroid tumors with known gene alteration

Mastnikova Karolina , Bulanova Barbora , Kuklikova Vlasta , Vaclavikova Eliska , Carkova Jitka , Katra Rami , Vlcek Petr , Kodetova Daniela , Chovanec Martin , Drozenova Jana , Matej Radoslav , Astl Jaromir , Hlozek Jiri , Soukup Jiri , Vcelak Josef , Bendlova Bela

Objectives: Molecular testing of thyroid tumors is increasingly being used for the diagnosis and prognosis of patients. In some cases, however, the same gene variant may be present in both benign and malignant thyroid tissue. The issue is also a different nature (aggressiveness) of carcinomas of the same genetic origin. Comparing of DNA methylation profiles of these samples could be a possible way of distinguishing these cases. Aim of this pilot study was to analyze the DNA me...